Schulman IRB Becomes Veeva Technology Partner

CINCINNATI and DURHAM, N.C., Jan. 19, 2017 /PRNewswire/ -- Schulman IRB, the industry-leading central IRB in customer service and technology, announces its integration with Veeva Systems.

"In recent years, we've developed integration tools to connect eTMF systems directly with our WebPortal platform," said Michael Woods, President and CEO at Schulman IRB. "As a leading global provider of cloud-based software solutions for the life sciences industry, Veeva is an ideal integration partner. Their system seamlessly integrates with our technology while also providing our users with an easy-to-use interface."

The Veeva Vault eTMF integration with Schulman's best-in-lass WebPortal platform offers real-time IRB status information and approval documentation seamlessly and allows mutual clients to customize the interface to address unique needs. The integration offers users unparalleled transparency and efficiency and significantly reduces error rates and resource expenditure. 

About Schulman IRB

Schulman IRB has been a leader in the protection of human research participants in the U.S., Puerto Rico and Canada since 1983. Schulman offers thorough, timely IRB review services –including dedicated review capabilities for all phases of research across all therapeutic areas – to clinical trial sponsors, CROs, investigators and institutions. Schulman also provides global consulting services, offering comprehensive solutions to maximize the protection of human subjects and improve overall quality standards for clinical studies and data integrity. Fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), Schulman has an unparalleled clean audit history with the Food and Drug Administration (FDA).

For more information, please visit http://www.sairb.com or follow @SchulmanIRB on Twitter or on LinkedIn.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/schulman-irb-becomes-veeva-technology-partner-300393838.html

SOURCE Schulman IRB

[ Back To TMCnet.com's Homepage ]